Financials • Specialty Insurers
$27.15 ▼ -0.13
(-0.48%)
MKT CAP: $1.47B • VOL: 117.2K
52W L $17 52W H $31
ROARABLE / RQD
C+ • 67/100
PIOTROSKI
4 / 9
TWFG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $248.5M | $203.8M | $172.0M |
| YoY Revenue Growth % | +22.0% | +18.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $37.0M | $27.9M | $25.4M |
| Operating Margin % | 14.9% | 13.7% | 14.8% |
| Net Income (GAAP) | $0 | $2.7M | $0 |
| EBITDA (Normalized) | $37.3M | $30.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $53.5M | $40.5M | $30.2M |
| Capital Expenditures (CapEx) | $356.0K | $3.2M | — |
| Free Cash Flow (FCF) | $53.1M | $37.3M | $30.2M |
| FCF Margin % | 21.4% | 18.3% | 17.5% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $155.9M | $195.8M | — |
| Total Debt (Short + Long Term) | $2.0M | $4.0M | — |
| Total Stockholders' Equity | $83.4M | $73.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR TWFG.